Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc.

World Rank (Jan-05-2024)
19,715
Market Cap (Jan-05-2024)
0.141 Billion USD
World Rank (Jul-30-2023)
18,487
Market Cap (Jul-30-2023)
0.185 Billion USD
World Rank (Jan-07-2022)
19,192
Market Cap (Jan-07-2022)
0.185 Billion USD
World Rank (Jan-01-2021)
7,370
Market Cap (Jan-01-2021)
1.154 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
BDTX
Market Cap (Mar-08-2026)
0.12
Employee Count
31
Employee Count as of Date
As on January-2020
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-67 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Balance Sheet for Period Ending
Dec-2020 ending year
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
BLACK DIAMOND THERAPEUTICS, INC.
Company Profile
Black Diamond Therapeutics is a Precision Oncology Medicine Company Pioneering the Discovery of Small Molecule and Tumor Agnostic Therapies. The company annual revenue is 154.7 million USD and 58 employees as on 2019. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share